. | Univariate Analysis . | Multivariate Analysis . | ||
---|---|---|---|---|
Prognostic factor | HR (95% CI) | P-value | HR (95% CI) | P-value |
Sex (male) | 2.00 (0.96–4.18) | .065 | 2.12 (0.98–4.61) | .058 |
Age (>70 years) | 2.88 (1.38–6.00) | .005* | 2.69 (1.19–6.10) | .018* |
KPS score (≤80 points) | 1.96 (0.92–4.18) | .082 | 0.93 (0.40–2.16) | .862 |
Resection (90%>) | 2.24 (1.06–4.73) | .035* | 2.05 (0.92–4.58) | .079 |
PTEN loss and/or mut | 0.20 (0.08–0.46) | <.001* | 0.29 (0.11–0.76) | .012* |
. | Univariate Analysis . | Multivariate Analysis . | ||
---|---|---|---|---|
Prognostic factor | HR (95% CI) | P-value | HR (95% CI) | P-value |
Sex (male) | 2.00 (0.96–4.18) | .065 | 2.12 (0.98–4.61) | .058 |
Age (>70 years) | 2.88 (1.38–6.00) | .005* | 2.69 (1.19–6.10) | .018* |
KPS score (≤80 points) | 1.96 (0.92–4.18) | .082 | 0.93 (0.40–2.16) | .862 |
Resection (90%>) | 2.24 (1.06–4.73) | .035* | 2.05 (0.92–4.58) | .079 |
PTEN loss and/or mut | 0.20 (0.08–0.46) | <.001* | 0.29 (0.11–0.76) | .012* |
KPS, Karnofsky Performance Status; mut, mutation.
*indicates statistical significance.
. | Univariate Analysis . | Multivariate Analysis . | ||
---|---|---|---|---|
Prognostic factor | HR (95% CI) | P-value | HR (95% CI) | P-value |
Sex (male) | 2.00 (0.96–4.18) | .065 | 2.12 (0.98–4.61) | .058 |
Age (>70 years) | 2.88 (1.38–6.00) | .005* | 2.69 (1.19–6.10) | .018* |
KPS score (≤80 points) | 1.96 (0.92–4.18) | .082 | 0.93 (0.40–2.16) | .862 |
Resection (90%>) | 2.24 (1.06–4.73) | .035* | 2.05 (0.92–4.58) | .079 |
PTEN loss and/or mut | 0.20 (0.08–0.46) | <.001* | 0.29 (0.11–0.76) | .012* |
. | Univariate Analysis . | Multivariate Analysis . | ||
---|---|---|---|---|
Prognostic factor | HR (95% CI) | P-value | HR (95% CI) | P-value |
Sex (male) | 2.00 (0.96–4.18) | .065 | 2.12 (0.98–4.61) | .058 |
Age (>70 years) | 2.88 (1.38–6.00) | .005* | 2.69 (1.19–6.10) | .018* |
KPS score (≤80 points) | 1.96 (0.92–4.18) | .082 | 0.93 (0.40–2.16) | .862 |
Resection (90%>) | 2.24 (1.06–4.73) | .035* | 2.05 (0.92–4.58) | .079 |
PTEN loss and/or mut | 0.20 (0.08–0.46) | <.001* | 0.29 (0.11–0.76) | .012* |
KPS, Karnofsky Performance Status; mut, mutation.
*indicates statistical significance.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.